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Studies of herpes simplex virus type 1 (HSV-1) infection have shown that many known and unknown cellular molecules in-
volved in viral proliferation are up-regulated following HSV-1 infection. In this study, using two-dimensional polyacrylamide 
gel electrophoresis, we found that the expression of the HSV-1 infection response repressive protein (HIRRP, GI 16552881) 
was up-regulated in human L02 cells infected with HSV-1. HIRRP, an unknown protein, was initially localized in the cyto-
plasm and then translocated into the nucleus of HSV-1-infected cells. Further analysis showed that HIRRP represses HSV-1 
proliferation by inhibiting transcription of the viral genome by interacting with the cellular transcription factor, ATF5, via its 
N-terminal domain. ATF5 represses the transcription of many host genes but can also act as an activator of genes containing a 
specific motif. We found that ATF5 promotes the proliferation of HSV-1 via a potential mechanism by which ATF5 enhances 
the transcription of viral genes during the course of an HSV-1 infection; HIRRP then induces feedback repression of this tran-
scription by interacting with ATF5. 
herpes simplex virus type 1 (HSV-1), HSV-1 infection response repressive protein (HIRPP), ATF5, transcriptional regu- 
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Herpes simplex virus type 1 (HSV-1) infections are fre-
quently impaired by molecules that are induced at different 
phases by specific cellular responses to virus infection [1,2]. 
This implies that many HSV-1 virions are required to main-
tain the infectious state and that they facilitate the survival 
of the virus through interactions with various cellular mol-
ecules [3,4]. A variety of specific gene transcription regula-
tory mechanisms are active during the course of HSV-1 
infection. Interactions between viral and cellular molecules 
generate a specific microenvironment during HSV-1 infec-
tion [5,6], leading to either lytic or latent infections in dif-
ferent host cells [713].  
When HSV-1 enters the epithelium, cis-activation of the 
viral genome is triggered by a specific motif (TgACgTCAA) 
in the promoter region of the viral immediate early (IE) 
gene. This motif is recognized by the tegument protein 
(VP16) in conjunction with the host proteins Oct1 and HCF. 
This cis-activation event induces the sequential transcription 
of IE, early (E) and late genes [1416] and leads to a lytic 
infection [17]. With respect to the entry of HSV-1 into neu-
ral cells, a deficiency in the Oct1 transcription factor is 
likely to contribute to the silencing of viral genes [18], sub-
sequently affecting the production of the viral RNA laten-
cy-associated transcript (LAT) [19]. Although these find-
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ings reveal some basic features of HSV-1 infection [20], the 
details of the molecular mechanisms involved remain un-
clear. HSV-1 infection studies involving mRNA differential 
display reverse transcription polymerase chain reaction 
(RT-PCR), 2D electrophoresis and microRNA analyses 
have provided further insights [2123]. These studies re-
vealed that many more cellular and viral molecules, includ-
ing viral RNAs, are involved in the initial stages of HSV-1 
infection than previously thought [24,25]. During these ini-
tial stages, the expression of certain cellular molecules is 
up-regulated as part of the host immune response; these 
molecules then activate viral transcription and interfere with 
viral proliferation. Molecules encoded by the viral genome 
are associated with its replication activity [26].  
The expression levels of some of these functional viral 
and cellular proteins are up-regulated in human fibroblasts 
following HSV-1 infection [2729]. Several cellular mole-
cules have negative functions with respect to the regulation 
of viral gene transcription. This differs from the conven-
tional interferon response, which restricts viral replication 
by affecting the cellular transcriptional regulatory system 
[21,30,31]. In this study, we aimed to determine which cel-
lular and viral molecules are involved in the transcriptional 
regulation of HSV-1. 
1  Materials and methods 
1.1  Cells and viruses 
The L02 (human liver), Vero (African green monkey kid-
ney), HeLa (human cervical carcinoma) and 293T (human 
kidney) cell lines were obtained from the ATCC (Manassas, 
VA, USA) and maintained in Dulbecco’s modified Eagle’s 
medium (DMEM; Highclone, Grand Island, NY, USA) 
supplemented with 10% fetal calf serum (FCS). The HSV-1 
F strain was maintained by the Institute of Medical Biology, 
Chinese Academy of Medical Sciences. Virus samples  
(100 µL) that had been serially diluted 10-fold were added 
to the wells of 96-well culture plates containing Vero cells 
(1×104 cells/well). The plates were incubated at 37°C/5% 
CO2 for 6–7 d, until viral cytopathic effects (CPE) were 
assessed. Greater than 50% CPE was considered to be in-
dicative of viral infection.  
1.2  Virus titration 
For virus adsorption, virus stocks (1 mL) were serially di-
luted 10-fold (1:10–1:100000), and 500 µL of the diluted 
stocks was added to wells of 6-well plates that had been 
coated with Vero cells for 1 h. Pre-warmed 2× DMEM was 
added to a 1:1 mixture of 2% (w/v) agarose and 2% (w/v) 
agar. This mixture was then added to the wells containing 
adsorbed virus, and the plates were incubated at 37°C for 
4–5 d until plaque formation was observed. We added   
1.5 mL of 4% (w/v) paraformaldehyde to each well and 
incubated the plates at room temperature for 1 h; 0.5% (w/v) 
crystal violet was added to assist with visualizing the 
plaques. 
1.3  Plasmid generation 
All primers used in this study are listed in Table 1. The 
hirrp gene, encoding the HSV-1 infection response repres-
sive protein (HIRRP), was amplified using cDNA reverse 
transcribed from the total RNA of infected 293 cells as a 
template. Total RNA was extracted from the infected cells 
using a Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) 
and reverse-transcribed using a Quantscript RT Kit 
(TIANGEN, China). Two specific primers were used 
(HIRRP-F and HIRRP-R; Table 1), and the resulting am-
plicon was digested with the EcoR I and Xho I restriction 
endonucleases and cloned into the pcDNA3 plasmid vector 
(Invitrogen, Carlsbad, CA, USA) to generate pcDNA3- 
HIRRP. We digested pcDNA3-HIRRP with EcoR I and Sal I 
and cloned the products into pEGFP-N2 (Clontech, Palo 
Alto, CA, USA) to create pGEFP-HIRRP. This vector was 
then subjected to digestion with EcoR I and Sal I, and the 
products were cloned into pGEX-5X-1 (Amersham, Pisca-
taway, NJ, USA) to generate pGEX-HIRRP. The pGEX- 
HIRRP plasmid was digested with EcoR I and Sal I, and the 
resulting products were cloned into pGBKT7 (Clontech, 
Palo Alto, CA, USA) to yield pGBKT7-HIRRP.  































F: AGAAGUCUGUCAUGCUCAAGU Hirrp RNAi 
fragments R: UUGAGCAUGACAGACUUCUGC 
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A fragment of the N-terminus of the hirrp gene (nucleo- 
tides 1–420) was amplified using primers HIRRP-N-F and 
HIRRP-N-R (Table 1). The amplicon was digested with 
EcoR I and Xho I, and the resulting products were cloned 
into pcDNA3 to give pcDNA3-HIRRP-N. A fragment of 
the C-terminus of the hirrp gene (nucleotides 241–630) was 
amplified using primers HIRRP-C-F and HIPPR-C-R (Ta-
ble 1). The amplicon was digested with EcoR I and Xho I 
and cloned into pcDNA3 to obtain the pcDNA3-HIRRP-C 
plasmid. 
An atf5 gene fragment encoding the ATF5 protein was 
amplified by polymerase chain reaction (PCR) using DNA 
from 293 cells as a template and primers ATF5 F and ATF5 
R. The resulting PCR products were digested with EcoR I 
and Xho I and cloned into pcDNA3 to generate pcDNA3- 
ATF5. This plasmid was then digested with EcoR I and Xho I 
and cloned into pGADT7 (Clontech, Palo Alto, CA, USA) 
to produce pGADT7-ATF5. The portion of atf5 encoding 
amino acids 163–283 of ATF5 was amplified using primers 
ATF5 C-F and ATF5 C-R; the resulting amplicon was di-
gested with EcoR I and Xho I and cloned into pGADT7 to 
generate pGADT7-ATF5-C.  
1.4  Cell transfection 
Cells were grown to approximately 80% confluence; the 
culture medium was then aspirated, and the cells were 
washed twice with phosphate-buffered saline (PBS). 
Lipofectamine 2000 (2 μL; Invitrogen, Carlsbad, CA, USA) 
and plasmid DNA (0.8 μg) were diluted separately in 
DMEM lacking FCS and antibiotics and then thoroughly 
mixed and incubated at 37°C for 20 min before being added 
to the cells. The cell cultures were incubated with the trans-
fection mixtures at 37°C for 6 h. The transfection mixtures 
were then aspirated and replaced with normal growth media. 
1.5  Immunofluorescence assays 
Cells grown to approximately 70% confluence in 24-well 
plates were infected with HSV-1 at a multiplicity of infec-
tion (MOI) of 0.1. Cells at 24 and 48 h post-infection (hpi) 
were fixed with pre-chilled 4% paraformaldehyde in PBS at 
room temperature for 15 min. The cells were permeabilized 
with PBS containing 0.2% (v/v) Triton X-100 for 10 min 
and then blocked with PBS containing 1% (w/v) bovine 
serum albumin (BSA; PBS-BSA buffer) for 60 min. The 
cells were incubated with HIRRP anti-serum overnight at 
4°C and washed with PBS-BSA, followed by incubation 
with a FITC-labeled anti-mouse antibody (1:20000, Abcam, 
Cambridge, UK) at room temperature for 30 min. The cells 
were observed using a fluorescence microscope. 
1.6  Northern blot analysis 
Total cellular RNA was extracted from HSV-1-infected L02 
cells (MOI=0.1) at 6 and 12 hpi using TRIZOL (Invitrogen, 
Carlsbad, CA, USA). The extracted RNA was subjected to 
denaturing electrophoresis in 1% formaldehyde and trans-
ferred to a nylon membrane for hybridization with 
γ-32P-labeled probes (PerkinElmer, Wellesley, MA, USA). 
The 18S rRNA was used as an internal control. X-ray auto-
radiography was conducted according to the manufacturer’s 
recommendations (Thermo Scientific, Rockford, IL, USA). 
1.7  Quantitative PCR (qPCR) 
Extracted cellular total RNA (TaKaRa, Japan) was re-
verse-transcribed into cDNA (Promega, Madison, WI, 
USA). The mRNAs encoding HIRRP, ICP0, TK, gC, gB 
and β-actin (reference gene) were amplified using the ap-
propriate cDNA as a template for the Real Master Mix 
(SYBR Green) PCR system (TaKaRa, Japan). The thermal 
cycling parameters involved an initial denaturation step at 
95°C for 3 min, followed by 35 cycles of 95°C for 10 s, 
56°C for 1 min, and 68°C for 40 s. Each experiment was 
repeated three times, with expression levels quantified using 
the 2△△CT method, where CT indicates the cycle threshold 
[32]. The data were analyzed using GraphPad Prism 4.0 
(GraphPad Software Inc., San Diego, CA, USA) with values 
presented as mean±standard error (SE) of three replicate 
samples. 
1.8  Western blot analysis 
L02 cells were grown to 80%–90% confluence and infected 
with HSV-1 at an MOI of 0.1. The cells were harvested at 0, 
12, 24, 36, and 48 hpi and lysed in RIPA buffer (50 mmol 
L1 Tris-HCl, 150 mmol L1 NaCl, 1% NP40, 0.5% sodium 
deoxycholate, 0.1% SDS, 1 mmol L1 PMSF, 2 μg mL1 
aprotinin and 2 μg mL1 leupeptin). The lysates were gently 
shaken at 4°C for 1 h, and the supernatants were collected. 
Proteins were then isolated by sodium dodecyl sulfate pol-
yacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to polyvinylidene difluoride (PVDF) membranes 
(Thermo Scientific, Rockford, IL, USA). The glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) protein was 
used as a reference. The membranes were blocked with 
Tris-buffered saline (TBS) supplemented with 0.1% Tween 
20 and 5% BSA (TTBS-BSA), followed by incubation with 
mouse HIRRP anti-serum (1:1000 dilution) at 4°C over-
night. The membranes were washed three times in TTBS 
and incubated with HRP-anti-mouse IgG (1:20000, Jackson, 
West Grove, PA, USA) at room temperature for 60 min. 
X-ray autoradiography was conducted in accordance with 
the manufacturer’s instructions. Semi-quantitation using 
images was conducted with GelPro 3.1 (Media Cybernetics, 
MD, USA). The antiserum against HIRRP was raised in 
BALB/c mice immunized twice with the fusion of that pro-
tein and glutathione S-transferase (GST). 
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1.9  Yeast two-hybrid assays 
AH109 yeast (Clontech, Palo Alto, CA, USA) transformed 
with recombinant pGBKT7-HIRRP was plated onto agar 
containing an SD/-Ade, SD/-His, SD/-Leu or SD/-Trp defi-
cient medium and incubated at 30°C for 5–7 d. The AH109 
(BD-HIRRP) culture was incubated with 1 mL of a human 
liver AD-cDNA library culture (Clontech, S1334, Lot 
6010080) at 30°C overnight. The cells were shaken at 
30–50 r min1 on a platform shaker for 24 h. Aliquots  
(100 µL) of the fused mixture were serially diluted 10-fold 
(1:10–1:10000) and seeded onto plates containing SD/-Leu, 
SD/-Trp, SD/-Leu or SD/-Trp. The remaining mixtures 
were plated onto TDO (SD/-His/-Leu/-Trp) and QDO 
(SD/-Ade/-His/-Leu/-Trp) agar, followed by reverse culti-
vation at 30°C until positive clones appeared. The positive 
clones were amplified in liquid medium to measure the 
β-galactosidase activity using pGADT7-T and pGBKT7- 
p53 as positive controls, and pGADT7 and pGBKT7 as 
negative controls. 
1.10  β-galactosidase activity 
The recombinant pGBKT7 plasmid containing hirrp (or its 
N- or C-terminal fragment) and the recombinant pGADT7 
plasmid containing atf5 (or its C-terminal fragment) were 
co-transfected into AH109 yeast cells. Positive clones 
grown on QDO plates were screened and then cultivated 
with gentle shaking (200 r min1) at 30°C for 36 h. The 
yeast cells were lysed after centrifugation and separated into 
three aliquots. Fresh ortho-nitrophenyl-β-galactoside (ONPG) 
was added to each aliquot, and the samples were incubated 
at 30°C until the solutions were yellow; β-galactosidase 
activity was then calculated. Combinations of pGBKT7 and 
pGADT7 with pGBKT7-p53 and pGADT7-T were used as 
negative and positive controls, respectively. Each experi-
ment was repeated five times, and the data were analyzed 
with GraphPad Prism 4.0. The values presented are 
mean±SE of five replicate samples. 
1.11  Co-immunoprecipitation 
Transfected and HSV-1-infected cells were collected and 
lysed in RIPA buffer with gentle shaking at 4°C for 1 h. The 
supernatants were collected, and protein A agarose (Sigma, 
St Louis, MO, USA) was used to capture the antigen-   
antibody complexes. The bound proteins were then sepa-
rated by SDS-PAGE and analyzed by Western blotting [14].  
1.12  Electrophoretic mobility shift assays (EMSAs) 
A nuclear protein lysis solution (Pierce, Rockford, IL, USA) 
was applied to transfected L02 cells at 48 h post-     
transfection, in accordance with the standard EMSA proto-
col for 6%–8% non-denaturing gel electrophoresis using 
biotin-labeled DNA probes. The lysate was incubated at 
room temperature for 30 min and then transferred to a nylon 
membrane and cross-linked using UV light for 10 min. The 
membranes were blocked with an EMSA-specific blocking 
solution at room temperature for 30 min. Peroxidase-labeled 
streptavidin (SAP, 1:500) was used to label the membranes, 
which were then subjected to X-ray autoradiography. 
1.13  RNA interference (RNAi) assays 
L02 cells transfected with RNAi fragments (Table 1) were 
infected with HSV-1 at an MOI of 0.1 at 24 h post-trans- 
fection. The total cellular RNA was then extracted at 36 hpi 
and reverse-transcribed into cDNA (Promega, Madison, WI, 
USA) following standard protocols. The resulting cDNA 
was stored at 20°C until required. The mRNA levels of 
ICP0, TK, gC, gB, and β-actin were determined using spe-
cific primers (Table 1) in qPCR assays. The data were ana-
lyzed using the 2△△CT method. 
2  Results 
2.1  Up-regulated expression of HIRRP is induced in 
HSV-1-infected cells 
We examined the possible correlation between the expres-
sion of HIRRP and HSV-1 infection (Figure S1 in Support-
ing Information). Interestingly, there was a significant 
up-regulation of hirrp mRNA in HSV-1- infected L02 cells 
at 6 hpi compared with that in uninfected cells (Figure 1A). 
This result was confirmed using qPCR assays, with mRNA 
levels in the infected cells increasing from 6 hpi (Figure 1B) 
and reaching 10-fold higher levels than in the control cells. 
Persistent expression of HIRRP was detected over the same 
period using Western blot assays (Figure 1C). 
2.2  Localization of HIRRP 
The subcellular localization of HIRRP was examined using 
green fluorescent protein (GFP)-tagged recombinant HIRRP. 
Our results showed that GFP-HIRRP was initially localized 
to the cytoplasm (Figures 2 and S2A in Supporting Infor-
mation) and then partially translocated to the nucleus in 
HSV-1-infected cells (Figure 2). To confirm this observa-
tion, we analyzed the localization of native HIRRP in 
HSV-1-infected L02 cells. HIRRP was observed in the cy-
toplasm of HSV-1-infected L02 cells and then in the nucle-
us as infection progressed (Figure S2B in Supporting In-
formation).  
2.3  HIRRP can inhibit HSV-1 replication 
The up-regulation of HIRRP was observed in HSV-1-  
infected L02 cells, and the expression of HIRRP in trans-
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Figure 1  HIRRP expression is up-regulated during HSV-1 infection in L-02 cells. A, Northern blots were used to analyze HIRRP expression following 
HSV-1 infection of L-02 cells. The total RNA from HSV-1-infected L-02 cells was used for Northern blot analysis. A 60-nt fragment was identified (nt 
121–180). B, Levels of hirrp mRNA detected by qPCR. C, Western blot assays were used to detect HIRRP in HSV-1-infected L-02 cells. 
 
Figure 2  HIRRP translocates from the cytoplasm to the nucleus in HSV-1-infected cells. L-02 cells were transfected with pEGFP-HIRRP and then infected 
with HSV-1. Assays were conducted at 36 hpi. Mock-infected, cells transfected with pEGFP-HIRRP and uninfected; infected, cells transfected with 
pEGFP-HIRRP and infected with HSV-1. Nuclei were stained with Hoechst 33258 (blue). 
fected cells reduced the replication efficiency of HSV-1 
approximately 24 hpi (Figure 3A). The up-regulated ex-
pression of HIRRP inhibited the transcription of the ICP0, 
TK and gC genes (Figure 3BD). The inhibitory effect on 
ICP0 was most obvious and occurred within 6 hpi (Figure 
3B), and the inhibition of TK and gC transcription occurred 
within 8–12 hpi (Figures 3C and D). These inhibitory ef-
fects were not observed in cells co-transfected with eukary-
otic expression vectors expressing the ICP0, TK, gC or 
HIRRP genes (Figure S3A–D in Supporting Information). 
2.4  Knocking-down HIRRP expression improves 
HSV-1 replication efficiency 
Next, the expression of hirrp was down-regulated using 
hirrp-specific microRNAs. Potential microRNA target sites 
in hirrp were identified using bioinformatics techniques, 
and three target sites were chosen (Figure S4A in Support-
ing Information). The miRNA-3 molecule significantly 
down-regulated hirrp transcription (Figure S4B in Support-
ing Information). In view of this down-regulation, the 
mRNA levels of ICP0, TK, gC and gB were examined at 12 
hpi in HSV-1-infected cells. Compared with the controls, 
miRNA-3 enhanced the transcription of all HSV-1 genes 
while knocking-down hirrp expression levels (Figure 4A). 
Virus titration assays conducted at 24, 36 and 48 hpi 
showed that viral replication efficiency increased dramati-
cally when HIRRP expression was blocked by miRNA-3 
(Figure 4B).  
2.5  HIRRP represses viral replication by interacting 
with ATF5 
The yeast-two hybrid system allowed us to identify several 
proteins that potentially interact with HIRRP, including the 
transcription factor ATF5. We then examined the interac-
tion between HIRRP and ATF5 using co-immunoprecipita- 
tion. HIRRP and ATF5 were co-precipitated in cells trans-
fected with either exogenous hirrp or atf5 (Figure 5A). 
HIRRP and ATF5 co-precipitated in HSV-1-infected cells 
(Figure 5B), and these results were confirmed by Western 
blotting. We found that the N-terminal domain of HIRRP 
bound to ATF5, whereas the C-terminal domain of ATF5 
did not bind to HIRRP (Figure S5A and B in Supporting 
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Figure 3  The overexpression of HIRRP inhibits HSV-1 replication. A, HIRRP expression affects HSV-1 proliferation in L-02 cells. Virus titration was 
conducted at 12, 24, 36, and 48 hpi. B, qPCR analysis of ICP0 gene expression in L-02 cells transfected with HIRRP. C, qPCR analysis of TK gene expres-
sion in L-02 cells transfected with HIRRP. D, qPCR analysis of gC gene expression in L-02 cells transfected with HIRRP. 
 
Figure 4  Down-regulating HIRRP expression in cells increases HSV-1 replication efficiency. A, The mRNA levels of ICP0, TK, gC and gB were in-
creased upon down-regulation of hirrp expression. The viral genes were detected by qPCR. B, Virus titration was conducted at 24, 36 and 48 hpi. 
Information). The hirrp deletion mutant DNA and atf5 were 
then co-transfected into cells that were subsequently infect-
ed with HSV-1. The growth dynamics of HSV-1 in these 
cells was analyzed using plaque assays (Figure 5C). Viral 
replication was repressed in cells transfected with the 
N-terminal region of hirrp and atf5 and in the positive con-
trol cells transfected with the whole hirrp expression plas-
mid. In contrast, the viral replication profile of cells trans-
fected with the C-terminal region of hirrp and atf5 was sim-
ilar to that of the negative control cells (Figure 5C). We 
observed an interaction between the HIRRP N-terminal 
peptide (17.9 kD) and ATF5 using co-immunoprecipitation 
and Western blotting in cells co-transfected with the hirrp 
N-terminal region and the atf5 gene. This result was con-
sistent with the results obtained for control cells transfected 
with the complete hirrp gene (Figure 5D). In contrast, 
co-immunopre- cipitation was not detected with cells trans-
fected with the hirrp C-terminal region (Figure 5D). 
2.6  HIRRP blocks ATF5 from binding to a specific 
motif in the viral RL2 gene 
The replication of HSV-1 was improved in L02 cells when 
ATF5 expression was up-regulated (Figure 6A). As a cellu-
lar transcription factor, ATF5 binds to up-stream response 
elements to regulate gene expression. Recent studies have 
revealed that ATF5 can bind to a specific motif (CCTC- 
TTCCTTA) and activate transcription [33]. As indicated in 
the whole genome analysis of the HSV-1 F strain, this motif 
is located at nucleotides 29212928, 47974804, 
48124819, 48484855, 1278712794, 9276292769 and 
121562121569 (within the ICP0, UL5, UL41 and UL42 
genes; Figure S6 in Supporting Information). Considering 
the interaction between ATF5 and HIRRP, we next used 
EMSA to investigate the status of ATF5 binding to the spe-
cific motif (CCTCTTCCTTA) in the presence and absence 
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Figure 5  HIRRP inhibits viral replication by interacting with ATF5. A, Co-immunoprecipitation confirmed the interaction between HIRRP and ATF5. 
L-02 cells were transfected with pcDNA3-ATF5 and/or pcDNA3-HIRRP. The complex was precipitated with antibodies to ATF5 (upper panel) or HIRRP 
(lower panel). B, Co-immunoprecipitation assay on HSV-1-infected cells. L-02 cells were infected with HSV-1. The complex was precipitated with an 
ATF5-specific antibody. C, Dynamics of virus growth during HSV-1 infection when the N- or C-terminus of HIRRP was deleted. The hirrp deletion mutants 
and atf5 were co-transfected into cells that were subsequently infected with HSV-1. Viral proliferation at 24, 36 and 48 hpi was assayed by titration. D, 
Co-immunoprecipitation confirmed the interaction between the N-terminus of HIRRP and ATF5. L-02 cells were transfected with pcDNA3-HIRRP, 
pcDNA3-HIRRP-N or pcDNA3-HIRRP-C. The complex was precipitated with an antibody to ATF5.  
of HIRRP. Our results indicate that the retardation of la-
beled DNA fragments containing the specific motif oc-
curred with eukaryotic cells expressing ATF5 alone, 
whereas no such binding was observed with cells co-   
expressing HIRRP and ATF5 (Figure 6C). These results 
indicate that ATF5 has the capacity to bind to the 
CCTCTTCCTTA motif (Figure 6B), whereas HIRRP can 
block this binding. However, determining whether this 
binding is directly linked to promoting transcriptional acti-
vation requires further investigation.  
We therefore cloned the specific motif and its down-
stream 3.4 kb region from the HSV-1 genome into a eukar-
yotic expression vector, pcDNA3, for transfection into hu-
man L02 cells. As shown by 2-D electrophoresis, no protein 
products were expressed in L02 cells transfected with 
pcDNA3 compared with control cells (data not shown). We 
designed 10 probes for Northern blot analysis, each repre-
senting a 340-bp fragment, to scan for potential RNA tran-
scription products within transfected cells. We detected one 
RNA transcript (370 nt; Figure 6D), indicating that tran-
scription promoted by the specific motif could generate at 
least one RNA molecule of as-yet unknown function. Fur-
ther experiments comparing the levels of this RNA mole-
cule in cells with up- and down-regulated HIRRP expres-
sion suggested a correlation between the expression levels 
of this RNA and HIRRP (Figure 6E). We were able to iden-
tify this RNA molecule as a transcript of the HSV-1 genome 
(Figure 6F). 
3  Discussion 
Characterizing events during HSV-1 infection has enabled 
us to identify new cellular molecules involved in combating 
these infections [28]. HIRRP is a cellular response molecule 
that is up-regulated in HSV-1-infected cells and has been 
linked to the repression of viral replication. Here, we show 
that the overexpression of HIRRP reduces the replication 
efficiency of HSV-1 and the mRNA levels of its α, β and γ 
genes (Figure 3). In line with these results, the knock-down 
of hirrp enhanced the HSV-1 replication efficiency and the 
transcription of viral genes (Figure 4). By contrast, HIRRP 
overexpression did not impair the expression of the α, β and 
γ genes in transfected cells (Figure S3 in Supporting Infor-
mation). The antiviral function of HIRRP appears to occur 
at the viral genome level; this notion is consistent with the 
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observation that HIRRP translocates from the cytoplasm to 
the nucleus during HSV-1 infection (Figure 2). Our findings 
suggest that HIRRP affects HSV-1 replication by binding to 
the N-terminus of ATF5 (Figures 5; Table S1, Figure S5 in 
Supporting Information). ATF5 has been reported to regu-
late viral transcription by binding to specific DNA frag-
ments via a leucine zipper motif [34]. These binding sites 
have been identified as the CRE motif (TgAgCT) and are 
present in non-coding regions of the HSV-1 α gene [35]. 
Most reports have shown that ATF5 exerts an inhibitory 
effect on transcription after binding to CRE motifs [36], 
suggesting a potential inhibitory effect on HSV-1 gene 
transcription. In our study, HSV-1 replication in cells was 
enhanced when the expression of ATF5 was up-regulated 
with pcDNA3-ATF5 (Figure 6A). Our findings also suggest 
that the transcription of the ICP0 gene, which has a similar 
CRE motif, was not affected by HIRRP inhibition. ICP0 
transcription and viral replication were inhibited following 
HSV-1 infection (Figures 3A and S3 in Supporting Infor-
mation). Furthermore, ATF5 has been reported to bind to a 
specific DNA motif (CCTCTTCCTTA) and initiate the 
transcription of downstream sequences [33]. This motif is 
present in the HSV-1 RL2 gene and in other regions (Figure 
6B). As shown by EMSA, ATF5 bound to this motif but 
lost this binding ability in the presence of HIRRP (Figure 
6C). These results imply that ATF5 activates transcription 
by binding to a specific motif in the viral DNA. This is pre-
sumed to be significant in enhancing viral transcription. The 
interaction between HIRRP and ATF5 causes ATF5 to lose 
its capacity to bind to this motif, thereby impairing the 
transcription of viral genes and the replication of the virus. 
The analysis of the 3.4 kb downstream sequence of the spe-
cific motif (CCTCTTCCTTA) revealed that its associated 
protein and RNA molecules were expressed. The binding of 
ATF5 to this DNA motif induced the transcription of an 
RNA molecule rather than viral proteins (Figure 6C). We 
propose a putative genomic transcription model, in which 
during HSV-1 infection, the binding of ATF5 to a specific 
DNA motif (CCTCTTCCTTA) induces the expression of an 
RNA molecule from the 3.4 kb viral sequence; this RNA, in 
turn, causes enhanced transcriptional activation of the viral 
genome. According to previous reports, the transcriptional 
activation of HSV-1 is initiated by the VP16-Oct1-HCF 
complex. The results of this study reveal an important RNA 
molecule that is produced by the activation of viral tran-
scription by cellular transcription factors and that interacts 
with HIRRP. We have provided new insights into the 
mechanisms of transcriptional regulation for the HSV-1 
genome. However, the mechanisms by which this RNA 
molecule enhances transcription and possibly interacts with 
the VP16-Oct1-HCF complex require further investigation.
 
 
Figure 6  ATF5 binding to motifs in the RL2 gene activates transcription. A, Up-regulating the expression of ATF5 can increase HSV-1 replication effi-
ciency. Virus titration was conducted for cells transfected with pcDNA3-ATF5 and/or pcDNA3 at 12, 24, 36, 48 hpi. B, Two specific motifs located within 
the RL2 gene are recognized by ATF5. C, EMSA to determine the DNA-binding capacity of ATF5 in cells co-transfected with ATF5 and HIRRP. L-02 cells 
were transfected with pcDNA3-ATF5 and/or pcDNA3-HIRRP. D, Northern blot analysis of transcripts regulated by the ATF5 binding motifs in the RL2 
gene. The 18S rRNA was used as an internal control. E, Expression analysis showed a 370-nt RNA that is correlated with HIRRP levels. The expression of 
hirrp was reduced following HSV-1 infection using the hirrp-specific miRNA-3. The 18S rRNA was used as an internal control. F, An RNA molecule 
bound to the 370-nt motif was identified in the virus genome. 
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Supporting Information 
Figure S1  2-D analysis of HSV-1-infected human L-02 cells. A, 2-D electrophoresis analysis of mock-infected L-02 cells. B, 2-D electrophoresis analysis 
of HSV-1-infected L-02 cells. ‘G’ indicates a difference in protein expression identified in infected cells.  
Figure S2  Localization and translocation of HIRRP in HSV-1-infected cells. A, Localization of HIRRP in Vero, Hela and 293T cells. Nuclei were stained 
with Hoechst 33258 (blue). B, Immunofluorescence assays were used to detect HIRRP expression in HSV-1-infected cells. The experiments were conducted 
at 36 hpi. 
Figure S3  Inhibition of ICP0, TK and gC expression when co-transfecting their genes and HIRRP. A, Schematic of expression vectors for ICP0, TK and 
gC. B, qPCR analysis of ICP0 gene expression in L-02 cells co-transfected with HIRRP and ICP0 (including the 5′ terminus ICP0 promoter). C, qPCR anal-
ysis of TK gene expression in L-02 cells transfected with HIRRP and TK (including the 5′ terminus TK promoter). D, qPCR analysis of gC gene expression 
in L-02 cells transfected with HIRRP and gC (including the 5′ terminus gC promoter). 
Figure S4  The miRNA-3 molecule down-regulates hirrp transcription. A, Three potential microRNA target sites in hirrp were predicted (blue, italicized). 
B, qPCR analysis of hirrp gene expression in L-02 cells knocked-down with miRNA-3. 
Figure S5  Analysis of the interaction between HIRRP and ATF5 using a yeast two-hybrid assay system. A, Schematic of the HIRRP structural domains 
based on various deletion mutants. B, Binding analysis of HIRRP and ATF5 domains. 
Figure S6  Schematic of DNA motifs identified in ATF5. IR, internal repeat; TR, terminal repeat; UL, unique long; US, unique short. 
The supporting information is available online at life.scichina.com and www.springerlink.com. The supporting materials 
are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains en-
tirely with the authors. 
